You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Express Scripts
McKesson
Medtronic
Harvard Business School

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022113


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 022113 describes ADVIL MULTI-SYMPTOM COLD & FLU, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from two suppliers. Additional details are available on the ADVIL MULTI-SYMPTOM COLD & FLU profile page.

The generic ingredient in ADVIL MULTI-SYMPTOM COLD & FLU is chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride profile page.
Suppliers and Packaging for NDA: 022113
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL ALLERGY AND CONGESTION RELIEF chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022113 NDA Wyeth Consumer Healthcare LLC 0573-0190 0573-0190-01 50 POUCH in 1 TRAY (0573-0190-01) > 1 TABLET, COATED in 1 POUCH
ADVIL ALLERGY AND CONGESTION RELIEF chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022113 NDA Wyeth Consumer Healthcare LLC 0573-0190 0573-0190-02 2 POUCH in 1 CARTON (0573-0190-02) > 1 TABLET, COATED in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength4MG;200MG;10MG
Approval Date:Dec 21, 2011TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength4MG;200MG;10MG
Approval Date:Apr 28, 2017TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Express Scripts
Dow
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.